Literature DB >> 31614121

GluT4: A central player in hippocampal memory and brain insulin resistance.

Ewan C McNay1, Jiah Pearson-Leary2.   

Abstract

Insulin is now well-established as playing multiple roles within the brain, and specifically as regulating hippocampal cognitive processes and metabolism. Impairments to insulin signaling, such as those seen in type 2 diabetes and Alzheimer's disease, are associated with brain hypometabolism and cognitive impairment, but the mechanisms of insulin's central effects are not determined. Several lines of research converge to suggest that the insulin-responsive glucose transporter GluT4 plays a central role in hippocampal memory processes, and that reduced activation of this transporter may underpin the cognitive impairments seen as a consequence of insulin resistance. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31614121      PMCID: PMC6936336          DOI: 10.1016/j.expneurol.2019.113076

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  225 in total

1.  Insulin protects against stress-induced impairments in water maze performance.

Authors:  M Moosavi; N Naghdi; N Maghsoudi; S Zahedi Asl
Journal:  Behav Brain Res       Date:  2006-11-20       Impact factor: 3.332

2.  Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor.

Authors:  S Hoyer; N Henneberg; S Knapp; H Lannert; E Martin
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

3.  Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet.

Authors:  Deborah J Clegg; Stephen C Benoit; Jacquelyn A Reed; Stephen C Woods; Ambrose Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-12-16       Impact factor: 3.619

4.  Cognitive function and information processing in type 2 diabetes.

Authors:  R Cosway; M W Strachan; A Dougall; B M Frier; I J Deary
Journal:  Diabet Med       Date:  2001-10       Impact factor: 4.359

Review 5.  Glucose, memory, and aging.

Authors:  D L Korol; P E Gold
Journal:  Am J Clin Nutr       Date:  1998-04       Impact factor: 7.045

6.  Intrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity.

Authors:  Danielle M Osborne; Dennis P Fitzgerald; Kelsey E O'Leary; Brian M Anderson; Christine C Lee; Peter M Tessier; Ewan C McNay
Journal:  Biochim Biophys Acta       Date:  2016-03-10

7.  The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus--potential role in modulation of glucose uptake in neurones?

Authors:  Ruani N Fernando; Anthony L Albiston; Siew Y Chai
Journal:  Eur J Neurosci       Date:  2008-08       Impact factor: 3.386

Review 8.  Insulin action on glucose transporters through molecular switches, tracks and tethers.

Authors:  Hilal Zaid; Costin N Antonescu; Varinder K Randhawa; Amira Klip
Journal:  Biochem J       Date:  2008-07-15       Impact factor: 3.857

Review 9.  Modulation of multiple memory systems: from neurotransmitters to metabolic substrates.

Authors:  Paul E Gold; Lori A Newman; Claire J Scavuzzo; Donna L Korol
Journal:  Hippocampus       Date:  2013-11       Impact factor: 3.899

Review 10.  Role of glucose in regulating the brain and cognition.

Authors:  P E Gold
Journal:  Am J Clin Nutr       Date:  1995-04       Impact factor: 7.045

View more
  21 in total

Review 1.  Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.

Authors:  Sukhee Cho; Hyein Lee; Jinsoo Seo
Journal:  Mol Neurobiol       Date:  2021-01-21       Impact factor: 5.590

Review 2.  Impaired insulin signalling and allostatic load in Alzheimer disease.

Authors:  Fernanda G De Felice; Rafaella A Gonçalves; Sergio T Ferreira
Journal:  Nat Rev Neurosci       Date:  2022-02-28       Impact factor: 34.870

Review 3.  Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

Authors:  Corey J Frank; Ewan C McNay
Journal:  J Neuroendocrinol       Date:  2021-12-13       Impact factor: 3.627

Review 4.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.

Authors:  Jennifer M Erichsen; Jim R Fadel; Lawrence P Reagan
Journal:  Neuropharmacology       Date:  2021-11-08       Impact factor: 5.250

5.  The Role of Zinc Status on Spatial Memory, Hippocampal Synaptic Plasticity, and Insulin Signaling in icv-STZ-Induced Sporadic Alzheimer's-Like Disease in Rats.

Authors:  Saltuk Bugra Baltaci; Omer Unal; Elif Gulbahce-Mutlu; Haluk Gumus; Suray Pehlivanoglu; Ahmet Yardimci; Rasim Mogulkoc; Abdulkerim Kasim Baltaci
Journal:  Biol Trace Elem Res       Date:  2021-11-02       Impact factor: 4.081

Review 6.  ApoE and cerebral insulin: Trafficking, receptors, and resistance.

Authors:  Elizabeth M Rhea; Jacob Raber; William A Banks
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

7.  Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model.

Authors:  Rofida A Saleh; Tarek F Eissa; Dalaal M Abdallah; Muhammed A Saad; Hanan S El-Abhar
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 8.  Targeting Insulin Resistance to Treat Cognitive Dysfunction.

Authors:  Anit Tyagi; Subbiah Pugazhenthi
Journal:  Mol Neurobiol       Date:  2021-01-23       Impact factor: 5.682

Review 9.  Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia.

Authors:  Amira Bryll; Justyna Skrzypek; Wirginia Krzyściak; Maja Szelągowska; Natalia Śmierciak; Tamas Kozicz; Tadeusz Popiela
Journal:  Biomolecules       Date:  2020-03-02

10.  N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.

Authors:  Li Zhou; Xiao Han; Wei Li; Ning Wang; Lan Yao; Yunhe Zhao; Liqun Zhang
Journal:  Reprod Sci       Date:  2021-07-12       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.